Valuation: CanSino Biologics Inc.

Market Cap 8.33B 9.63B 1.23B 1.07B 991M 913M 1.72B 118B 1.76B 11.84B 4.66B 57.94B 4.61B 4.51B 199B P/E 2026 *
33.8x
P/E 2027 * 12.5x
Enterprise Value 8.24B 9.53B 1.22B 1.06B 981M 904M 1.7B 117B 1.74B 11.72B 4.61B 57.35B 4.57B 4.47B 197B EV / Sales 2026 *
5.77x
EV / Sales 2027 * 4.32x
Free-Float
39.28%
Yield 2026 *
-
Yield 2027 * -
1 day-7.27%
1 week+3.48%
Current month+4.13%
1 month+3.39%
3 months-34.09%
6 months-37.93%
Current year-33.56%
1 week 22.72
Extreme 22.72
25.4
1 month 19.22
Extreme 19.22
25.4
Current year 19.22
Extreme 19.22
41.64
1 year 19.22
Extreme 19.22
56.55
3 years 14.8
Extreme 14.8
56.55
5 years 14.8
Extreme 14.8
398
10 years 14.8
Extreme 14.8
450
Manager TitleAgeSince
Corporate Officer/Principal 66 21/02/2024
Corporate Officer/Principal 64 13/01/2009
Chief Tech/Sci/R&D Officer 53 13/01/2009
Director TitleAgeSince
Chairman 62 13/01/2009
Director/Board Member 63 28/05/2021
Director/Board Member 63 22/06/2018
Date Insider Type Main position Quantity % Market Cap.
26/08/25 Sell

Director

4,600 0.0069%
26/09/24 Other

Chief Executive Officer

20,000 0.0151%
09/09/24 Other

Founder

30,000 0.0226%
Change 5-day change 1-year change 3-year change Capi.($)
-7.27%+3.48%-38.95%-13.11% 1.32B
-0.29%+2.01%+23.25%-6.06% 69.07B
+0.67%+0.93%+37.53%+198.53% 51.77B
+0.94%+39.60%+39.60%+39.60% 43.63B
+1.12%-1.76%-50.16%-52.75% 40.89B
-1.43%+3.86%+60.72%-25.71% 30.84B
-1.27%-8.74%+93.48%-49.18% 25.06B
+0.33%+0.40%+69.97%+91.85% 23.3B
-5.57%+3.01%+3.19%+174.11% 20.92B
-0.86%-1.99%+68.42%+124.39% 16.71B
Average -1.41%-0.24%+30.70%+48.17% 32.35B
Weighted average by Cap. -0.36%-1.30%+31.62%+47.13%

Financials

2026 *2027 *
Net sales 1.43B 1.65B 211M 184M 170M 157M 295M 20.28B 302M 2.03B 799M 9.93B 791M 774M 34.2B 1.79B 2.07B 265M 231M 213M 197M 371M 25.49B 379M 2.55B 1B 12.48B 994M 972M 42.97B
Net income 144M 167M 21.3M 18.62M 17.18M 15.83M 29.84M 2.05B 30.51M 205M 80.76M 1B 80M 78.24M 3.46B 395M 457M 58.28M 50.93M 47M 43.32M 81.65M 5.61B 83.46M 562M 221M 2.75B 219M 214M 9.46B
Net Debt -85.1M -98.43M -12.56M -10.97M -10.12M -9.33M -17.59M -1.21B -17.98M -121M -47.6M -592M -47.15M -46.12M -2.04B -581M -672M -85.66M -74.86M -69.08M -63.67M -120M -8.25B -123M -826M -325M -4.04B -322M -315M -13.91B
Logo CanSino Biologics Inc.
CanSino Biologics Inc is a China-based company primarily engaged in the research and development, production, and commercialization of human vaccine products. The Company’s products and product pipeline under research include multiple vaccine varieties such as meningitis, pneumonia, diphtheria, tetanus, and pertussis (DPT), coronavirus disease 2019 (COVID-19), Ebola virus disease, poliomyelitis, herpes zoster, tuberculosis and others. The Company is also engaged in the research and development of pharmaceutical production processes. The Company conducts its business in the domestic and overseas markets.
Employees
1,134
Date Price Change Volume
17/07/26 HK$23.20 -7.27% 898,040
16/07/26 HK$25.02 +2.12% 598,800
15/07/26 HK$24.50 +4.26% 1,062,399
14/07/26 HK$23.50 +0.43% 470,200
13/07/26 HK$23.40 -0.09% 740,687
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
21.62CNY
Average target price
43.59CNY
Spread / Average Target
+101.61%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6185 Stock